SCHEMBL3661601

SCHEMBL3661601

CCCCCCCCCCCCCCCC(=O)c1ccc(OC)cc1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.70
NPC1 O15118 4/20 0.57
RAB9A P51151 4/20 0.57
CYP3A4 P08684 3/20 0.55
HPGD P15428 3/20 0.55
ALDH1A1 P00352 2/20 0.55
MAPK1 P28482 1/20 0.55
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
MAPT P10636 1/20 0.53
ATM Q13315 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
TAS1R3 Q7RTX0 1/20 0.52
TAS1R1 Q7RTX1 1/20 0.52
KDM4E B2RXH2 1/20 0.51
HSD17B3 P37058 5/20 0.50
APP P05067 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
PGR P06401 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3663202 1.00 HTT (0.70) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3658682 1.00 HTT (0.70) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3659698 1.00 HTT (0.70) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3662822 1.00 HTT (0.70) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3658608 1.00 HTT (0.70) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3660499 1.00 HTT (0.70) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3658257 1.00 HTT (0.70) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3658080 1.00 HTT (0.70) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3662392 0.98 HTT (0.72) HTTNPC1RAB9ACYP3A4HPGD
SCHEMBL3660724 0.94 HTT (0.65) HTTNPC1RAB9ACYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC HTT 22/4885NPC1 4845/4885RAB9A 3880/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR HTT 2960/4885NPC1 3666/4885RAB9A 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.